छोड़कर सामग्री पर जाएँ

Latest News

Happiest Minds Technologies shares fall on weak Q3 earnings

Happiest Minds Technologies shares fall on weak Q3 earnings

For the December FY23 quarter, Happiest Minds recorded a 3.1 percent sequential decline in profit at Rs 57.6 crore

Read More

​ For the December FY23 quarter, Happiest Minds recorded a 3.1 percent sequential decline in profit at Rs 57.6 crore For the December FY23 quarter, Happiest Minds recorded a 3.1 percent sequential decline in profit at Rs 57.6 crore  Moneycontrol Latest News Read More  

For the December FY23 quarter, Happiest Minds recorded a 3.1 percent sequential decline in profit at Rs 57.6 crore

No, banks aren’t stronger than they need to be

No, banks aren’t stronger than they need to be

Capital standards have proven their worth. They should be restored, not weakened

Read More

​ Capital standards have proven their worth. They should be restored, not weakened Capital standards have proven their worth. They should be restored, not weakened  Moneycontrol Latest News Read More  

Capital standards have proven their worth. They should be restored, not weakened

Buy HDFC Bank; target of Rs 1890: Geojit

Buy HDFC Bank; target of Rs 1890: Geojit

Geojit is bullish on HDFC Bank has recommended buy rating on the stock with a target price of Rs 1890 in its research report dated January 19, 2023.

Read More

​ Geojit is bullish on HDFC Bank has recommended buy rating on the stock with a target price of Rs 1890 in its research report dated January 19, 2023. Geojit is bullish on HDFC Bank has recommended buy rating on the stock with a target price of Rs 1890 in its research report dated January 19, 2023.  Moneycontrol Latest News Read More  

Geojit is bullish on HDFC Bank has recommended buy rating on the stock with a target price of Rs 1890 in its research report dated January 19, 2023.

Neutral PSP Projects; target of Rs 764: YES Securities

Neutral PSP Projects; target of Rs 764: YES Securities

YES Securities recommended neutral rating on PSP Projects with a target price of Rs 764 in its research report dated January 18, 2023.

Read More

​ YES Securities recommended neutral rating on PSP Projects with a target price of Rs 764 in its research report dated January 18, 2023. YES Securities recommended neutral rating on PSP Projects with a target price of Rs 764 in its research report dated January 18, 2023.  Moneycontrol Latest News Read More  

YES Securities recommended neutral rating on PSP Projects with a target price of Rs 764 in its research report dated January 18, 2023.

Manasi Tata to helm Toyota Kiroloskar, takes charge as Vice Chair

Manasi Tata to helm Toyota Kiroloskar, takes charge as Vice Chair

Manasi Tata, who had joined the board of Toyota Kirloskar Motors in December as Director after her father#39;s demise, will now lead as the Vice Chairperson of both Toyota Kirloskar Motors and Toyota Kirloskar Auto Parts.

Read More

​ Manasi Tata, who had joined the board of Toyota Kirloskar Motors in December as Director after her father#39;s demise, will now lead as the Vice Chairperson of both Toyota Kirloskar Motors and Toyota Kirloskar Auto Parts. Manasi Tata, who had joined the board of Toyota Kirloskar Motors in December as Director after her father#39;s demise, will now lead as the Vice Chairperson of both Toyota Kirloskar Motors and Toyota Kirloskar Auto Parts.  Moneycontrol Latest News Read More  

Manasi Tata, who had joined the board of Toyota Kirloskar Motors in December as Director after her father#39;s demise, will now lead as the Vice Chairperson of both Toyota Kirloskar Motors and Toyota Kirloskar Auto Parts.

Buy ICICI Prudential Life Insurance; target of Rs 635: KR Choksey

Buy ICICI Prudential Life Insurance; target of Rs 635: KR Choksey

KR Choksey is bullish on ICICI Prudential Life Insurance has recommended buy rating on the stock with a target price of Rs 635 in its research report dated January 19, 2023.

Read More

​ KR Choksey is bullish on ICICI Prudential Life Insurance has recommended buy rating on the stock with a target price of Rs 635 in its research report dated January 19, 2023. KR Choksey is bullish on ICICI Prudential Life Insurance has recommended buy rating on the stock with a target price of Rs 635 in its research report dated January 19, 2023.  Moneycontrol Latest News Read More  

KR Choksey is bullish on ICICI Prudential Life Insurance has recommended buy rating on the stock with a target price of Rs 635 in its research report dated January 19, 2023.

Moneycontrol Pro Panorama | China shines light on emerging markets

Moneycontrol Pro Panorama | China shines light on emerging markets

In today’s edition of Moneycontrol Pro Panorama: Rural markets cautiously optimistic, fiscal consolidation needs more focus, time to make tax code simpler, green capex needs energisers to charge up, and more

Read More

​ In today’s edition of Moneycontrol Pro Panorama: Rural markets cautiously optimistic, fiscal consolidation needs more focus, time to make tax code simpler, green capex needs energisers to charge up, and more In today’s edition of Moneycontrol Pro Panorama: Rural markets cautiously optimistic, fiscal consolidation needs more focus, time to make tax code simpler, green capex needs energisers to charge up, and more  Moneycontrol Latest News Read More  

In today’s edition of Moneycontrol Pro Panorama: Rural markets cautiously optimistic, fiscal consolidation needs more focus, time to make tax code simpler, green capex needs energisers to charge up, and more

Luxury home developer Isprava raises Rs 160 crore, to expand India, overseas business

Luxury home developer Isprava raises Rs 160 crore, to expand India, overseas business

Isprava has built luxury homes in Goa, Alibaug, Kasauli and the Nilgiris. The money will be used for a more strategic purpose such as acquisition and inorganic growth, co-founder and CEO tells Moneycontrol

Read More

​ Isprava has built luxury homes in Goa, Alibaug, Kasauli and the Nilgiris. The money will be used for a more strategic purpose such as acquisition and inorganic growth, co-founder and CEO tells Moneycontrol Isprava has built luxury homes in Goa, Alibaug, Kasauli and the Nilgiris. The money will be used for a more strategic purpose such as acquisition and inorganic growth, co-founder and CEO tells Moneycontrol  Moneycontrol Latest News Read More  

Isprava has built luxury homes in Goa, Alibaug, Kasauli and the Nilgiris. The money will be used for a more strategic purpose such as acquisition and inorganic growth, co-founder and CEO tells Moneycontrol

Luxury home developer Isprava raises Rs 160 crore, to expand India, overseas business

Luxury home developer Isprava raises Rs 160 crore, to expand India, overseas business

Isprava has built luxury homes in Goa, Alibaug, Kasauli and the Nilgiris. The money will be used for a more strategic purpose such as acquisition and inorganic growth, co-founder and CEO tells Moneycontrol

Read More

​ Isprava has built luxury homes in Goa, Alibaug, Kasauli and the Nilgiris. The money will be used for a more strategic purpose such as acquisition and inorganic growth, co-founder and CEO tells Moneycontrol Isprava has built luxury homes in Goa, Alibaug, Kasauli and the Nilgiris. The money will be used for a more strategic purpose such as acquisition and inorganic growth, co-founder and CEO tells Moneycontrol  Moneycontrol Latest News Read More  

Isprava has built luxury homes in Goa, Alibaug, Kasauli and the Nilgiris. The money will be used for a more strategic purpose such as acquisition and inorganic growth, co-founder and CEO tells Moneycontrol

Budget 2023 wishlist: Pharma, healthcare industry seek simplified regulations, research-based incentives

Budget 2023 wishlist: Pharma, healthcare industry seek simplified regulations, research-based incentives

Budget 2023: Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said the domestic pharma industry is currently around USD 50 billion in size and aspires to grow to around USD 130 billion by 2030 and USD 450 billion by 2047.

Read More

​ Budget 2023: Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said the domestic pharma industry is currently around USD 50 billion in size and aspires to grow to around USD 130 billion by 2030 and USD 450 billion by 2047. Budget 2023: Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said the domestic pharma industry is currently around USD 50 billion in size and aspires to grow to around USD 130 billion by 2030 and USD 450 billion by 2047.  Moneycontrol Latest News Read More  

Budget 2023: Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said the domestic pharma industry is currently around USD 50 billion in size and aspires to grow to around USD 130 billion by 2030 and USD 450 billion by 2047.

hi_INहिन्दी